Clinical Trial Update: The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating 68Ga-PSMA-11 PET for guidance in prostate cancer surgery; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Clinton Bahler | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-07-27